New research reveals that patients who discontinue blockbuster slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass much more quickly than those who end conventional lifestyle regimens.
Published data in a leading medical journal demonstrates that while obese individuals often shed substantial amounts of their total mass while on the medication, the mass comes back at an average rate of nearly a kilo each month after stopping.
"Users using such treatments need to be informed of the potential of fast weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.
This pace of regain means a reversion to pre-treatment mass in about a year and a half.
Weighing Therapies
The research, which examined dozens of studies involving thousands of participants, contrasted the results of the injectable medications with older methods.
Scientists point out that people who shed pounds through lifestyle changes alone usually have a more gradual creep back—around 0.1 kg a month—after stopping.
Understanding the Quick Regain
Nutrition scientists suggest the mode of action of the jabs explains the amplified weight return.
GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production might result in the body to produce less of its own natural GLP-1, and may also lessen sensitivity to its effects," said Dr. Adam Collins, a dietetics specialist.
"Stopping of this hormone supplement results in hunger is uncontrolled, making binge eating a significant risk."
A Chronic Disease?
Medical guidelines recommend the jabs for people with obesity-related health risks, alongside prescribed diet and exercise modifications.
Professionals argue that, due to the likelihood of relapse, the therapy should be considered life-long.
This view is echoed by pharmaceutical companies, who note that the results "highlight the long-term nature of excess weight," akin to managing conditions like high blood pressure.
Patient Experiences
People who have discontinued the jabs report a sudden return of cravings.
"I experienced a trigger activating and you become extremely hungry," recalled one woman.
The struggle is worsened if individuals have not established sustainable dietary or behavioural modifications during treatment.
Growing Use
Recent estimates show that a significant number of adults in the UK have tried these injections in the past year, with interest remaining high.
- Adoption is higher among females compared to men.
- The 40s and 50s demographic shows the greatest level of interest.
- Many access the medications through private healthcare rather than the NHS.
Ultimately, researchers stress that while these medications are effective agents for shedding pounds, they are not a magic solution and lasting health benefits likely depends on ongoing behavioural management.